A detailed history of Wallace Capital Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Wallace Capital Management Inc. holds 10,512 shares of PFE stock, worth $275,519. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,512
Previous 10,190 3.16%
Holding current value
$275,519
Previous $285,000 6.67%
% of portfolio
0.04%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $8,919 - $10,107
322 Added 3.16%
10,512 $304,000
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $17,682 - $20,720
700 Added 7.38%
10,190 $285,000
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $245,696 - $282,137
9,490 New
9,490 $263,000
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $6,184 - $8,050
157 Added 2.67%
6,040 $246,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $40,539 - $52,919
-971 Reduced 14.17%
5,883 $301,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $43,278 - $52,832
-989 Reduced 12.61%
6,854 $300,000
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $186 - $220
4 Added 0.05%
7,843 $397,000
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $183 - $226
4 Added 0.05%
7,839 $379,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $165 - $245
4 Added 0.05%
7,835 $463,000
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $157 - $201
4 Added 0.05%
7,831 $337,000
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $179 - $203
5 Added 0.06%
7,827 $306,000
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $200 - $226
6 Added 0.08%
7,822 $294,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $16,735 - $21,280
500 Added 6.83%
7,816 $288,000
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $3,621 - $4,109
-110 Reduced 1.48%
7,316 $287,000
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $29,565 - $38,338
-910 Reduced 10.92%
7,426 $267,000
Q2 2019

Aug 12, 2019

BUY
$36.98 - $41.52 $3,365 - $3,778
91 Added 1.1%
8,336 $361,000
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $712 - $782
19 Added 0.23%
8,245 $350,000
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $1,961 - $2,236
-51 Reduced 0.62%
8,226 $359,000
Q3 2017

Nov 13, 2017

SELL
$31.0 - $34.15 $12,400 - $13,660
-400 Reduced 4.61%
8,277 $295,000
Q2 2017

Aug 14, 2017

BUY
N/A
8,677
8,677 $291,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wallace Capital Management Inc. Portfolio

Follow Wallace Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallace Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wallace Capital Management Inc. with notifications on news.